Azarias Capital Management L.P. trimmed its holdings in TrueBlue, Inc. (NYSE:TBI – Free Report) by 7.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,590,516 shares of the business services provider’s stock after selling 131,832 shares during the period. TrueBlue accounts for approximately 6.0% of Azarias Capital Management L.P.’s holdings, making the stock its 7th largest holding. Azarias Capital Management L.P. owned approximately 5.38% of TrueBlue worth $13,360,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in TBI. FMR LLC increased its stake in TrueBlue by 10.0% during the third quarter. FMR LLC now owns 1,742,474 shares of the business services provider’s stock worth $13,748,000 after acquiring an additional 158,967 shares during the last quarter. Royce & Associates LP raised its holdings in TrueBlue by 28.5% in the third quarter. Royce & Associates LP now owns 1,082,085 shares of the business services provider’s stock valued at $8,538,000 after buying an additional 239,740 shares during the period. State Street Corp increased its stake in TrueBlue by 0.3% during the 3rd quarter. State Street Corp now owns 665,901 shares of the business services provider’s stock worth $5,254,000 after buying an additional 1,968 shares during the period. Assenagon Asset Management S.A. increased its stake in TrueBlue by 33.1% during the 3rd quarter. Assenagon Asset Management S.A. now owns 386,432 shares of the business services provider’s stock worth $3,049,000 after buying an additional 96,072 shares during the period. Finally, GSA Capital Partners LLP lifted its holdings in TrueBlue by 85.2% in the 3rd quarter. GSA Capital Partners LLP now owns 220,892 shares of the business services provider’s stock worth $1,743,000 after buying an additional 101,589 shares in the last quarter. Hedge funds and other institutional investors own 97.15% of the company’s stock.
Wall Street Analysts Forecast Growth
TBI has been the topic of a number of analyst reports. BMO Capital Markets dropped their target price on TrueBlue from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 5th. StockNews.com lowered TrueBlue from a “hold” rating to a “sell” rating in a research note on Thursday, February 6th.
TrueBlue Price Performance
TBI opened at $7.30 on Thursday. TrueBlue, Inc. has a 12-month low of $6.63 and a 12-month high of $13.28. The stock has a market capitalization of $215.79 million, a PE ratio of -1.90, a P/E/G ratio of 3.66 and a beta of 1.42. The firm’s fifty day moving average price is $8.03 and its 200 day moving average price is $7.93.
TrueBlue Profile
TrueBlue, Inc, together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries.
See Also
- Five stocks we like better than TrueBlue
- Business Services Stocks Investing
- PayPal: Time to Strike With Shares Down Double Digits?
- Investing in the High PE Growth Stocks
- Lattice Semiconductor’s Market Reset Is Over: The Rebound Begins
- How to Effectively Use the MarketBeat Ratings Screener
- Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial
Receive News & Ratings for TrueBlue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TrueBlue and related companies with MarketBeat.com's FREE daily email newsletter.